Eikon Therapeutics
Paul Allegretti is a Principal Scientist at Eikon Therapeutics, having previously held roles as a Research Scientist at Theravance Biopharma US, Inc. and as a Postdoctoral Fellow at Stanford University School of Medicine. With a PhD in Organic Chemistry from Colorado State University, Paul also has experience as an Instructor at Colorado State University, teaching various chemistry courses.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.